| Followers | 65 |
| Posts | 10174 |
| Boards Moderated | 0 |
| Alias Born | 03/29/2015 |
Monday, August 04, 2025 1:25:03 AM
With $2+ being the SP on mere hope of TLD ‘coming soon’ (and that was in 2020 dollars before a whole lot of inflation happened) $5 after so many additional years will scarcely impress older, independent-minded investors.
$5 a share will be less than expected far later than expected (which ironically what is the ‘performance’ to be expected from NWBO).
$10 is a dream and far less likely to hold than $5 as too many seasoned investors have been burned by having misplaced faith in management and holding, falsely thinking ‘this is just the start’ and being loyal investors and not traders (like some here).
I suspect these loyal investors will lose heart this time around and sell at least a large part of their positions in any run up to $10 or when it crosses that threshold. This will create a self-fulfilling prophecy.
To be honest that dynamic is as almost as likely if it closes in on $5 a share.
Are there confidence-building measures NWBO management could undertake the foreseeable factors?
Yes.
They don’t need Nostradamus to tell them what will happen and what they need to do if they ever cared about loyal retail investors.
But will they they take decisive and effective action to protect and amplify an SP run up?
Probably not, but as always, maybe this time will be different.
$5 a share will be less than expected far later than expected (which ironically what is the ‘performance’ to be expected from NWBO).
$10 is a dream and far less likely to hold than $5 as too many seasoned investors have been burned by having misplaced faith in management and holding, falsely thinking ‘this is just the start’ and being loyal investors and not traders (like some here).
I suspect these loyal investors will lose heart this time around and sell at least a large part of their positions in any run up to $10 or when it crosses that threshold. This will create a self-fulfilling prophecy.
To be honest that dynamic is as almost as likely if it closes in on $5 a share.
Are there confidence-building measures NWBO management could undertake the foreseeable factors?
Yes.
They don’t need Nostradamus to tell them what will happen and what they need to do if they ever cared about loyal retail investors.
But will they they take decisive and effective action to protect and amplify an SP run up?
Probably not, but as always, maybe this time will be different.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
